The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Ton, re the cbx comment, i think the sports people target market will prefer synthetic, no chance of any thc (re drug tests). In the USA there was a real issue of "non" thc cannabis strains having more than was allowed. Hence the importance of us testing our varients and why we expected seed sales (which has gone quiet, presume being kept to meet our own massive growth targets).
Lots of others will buy cbx for same reasons i.e. Military personnel, govt workers, drivers, ex offenders - just to be double sure of not getting a positive drugs test.
This may change in future when more convidence/evidence about canna based cbd products/brands.
Well I managed to land 119k cbx, I sold all mine at 7:50 Friday pre open, my reasoning is, that once the consumer realises that the cbd is synthesised in a laboratory they won’t want to know, surely the natural product element of most cannabis plays is their strongest selling point?
To that end the amount of articles I’ve seen on cbx with a cannabis plant on the front headlines suggests to me even the reporters don’t quite get it yet. Remember we can make vinegar from North Sea oil, but consumers tend to go for the malted natural variety. Anyway who cares I bought more zoetic!
Next big ipo to look forward to is Pluto imho, and with ARB behind it should fly on listing, although sounds like will be on aquis, (initially anyway)who are apparently pulling out all the stops to get it listed ASAP. Anyway they don’t all work, but if that 4 bags too goes in here also.
I wasn’t pointing fingers, just that ours isn’t the only bb to suffer. Anyone can go and have a read and make their own mind up who’s who. Lots of ‘buy this, buy that’ as usual.
He likes to invest early
Interesting looking at CBX investors - John Story 15,000,000shares 3.0%
Yawn
Not really my friend just saying to think before investing. Hmm I never mentioned ZOE either or any of my other investments but you must be a tad worried to come over crying
Have been watching CBX and KNB boards and guess what? De-rampers everywhere, others plugging FPP and MGC. We’re being ignored so can just sit and hold onto these sleeping giant shares. It’s fun to watch tho - same BS there as we get here from the usual suspects. Muppets. Leave them to it!
Enjoy the peace for a while folks!